Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

343 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Surgical management of soft tissue tumors of the abdominal wall: A retrospective study in a high-volume sarcoma center.
Neuberg M, Mir O, Levy A, Sourrouille I, Dumont S, Haddag-Miliani L, Ngo C, Mihoubi F, Rimareix F, Le Péchoux C, Adam J, Honart JF, Ceribelli C, Le Cesne A, Leymarie N, Faron M, Honoré C. Neuberg M, et al. Among authors: mir o. J Surg Oncol. 2021 Sep;124(4):679-686. doi: 10.1002/jso.26566. Epub 2021 Jun 13. J Surg Oncol. 2021. PMID: 34120344 Free article.
[Taxane-induced skin toxicity and TNF-alpha].
Mir O, Adam J. Mir O, et al. Presse Med. 2008 Feb;37(2 Pt 1):252-3. doi: 10.1016/j.lpm.2007.09.014. Epub 2008 Jan 11. Presse Med. 2008. PMID: 18191367 French. No abstract available.
Doxorubicin and ifosfamide for high-grade sarcoma during pregnancy.
Mir O, Berrada N, Domont J, Cioffi A, Boulet B, Terrier P, Bonvalot S, Trichot C, Lokiec F, Le Cesne A. Mir O, et al. Cancer Chemother Pharmacol. 2012 Feb;69(2):357-67. doi: 10.1007/s00280-011-1707-8. Epub 2011 Jul 19. Cancer Chemother Pharmacol. 2012. PMID: 21769666 Clinical Trial.
Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trial.
Le Cesne A, Blay JY, Domont J, Tresch-Bruneel E, Chevreau C, Bertucci F, Delcambre C, Saada-Bouzid E, Piperno-Neumann S, Bay JO, Mir O, Ray-Coquard I, Ryckewaert T, Valentin T, Isambert N, Italiano A, Clisant S, Penel N. Le Cesne A, et al. Among authors: mir o. Lancet Oncol. 2015 Mar;16(3):312-9. doi: 10.1016/S1470-2045(15)70031-8. Epub 2015 Feb 11. Lancet Oncol. 2015. PMID: 25680558 Clinical Trial.
Paclitaxel Given Once Per Week With or Without Bevacizumab in Patients With Advanced Angiosarcoma: A Randomized Phase II Trial.
Ray-Coquard IL, Domont J, Tresch-Bruneel E, Bompas E, Cassier PA, Mir O, Piperno-Neumann S, Italiano A, Chevreau C, Cupissol D, Bertucci F, Bay JO, Collard O, Saada-Bouzid E, Isambert N, Delcambre C, Clisant S, Le Cesne A, Blay JY, Penel N. Ray-Coquard IL, et al. Among authors: mir o. J Clin Oncol. 2015 Sep 1;33(25):2797-802. doi: 10.1200/JCO.2015.60.8505. Epub 2015 Jul 27. J Clin Oncol. 2015. PMID: 26215950 Clinical Trial.
Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial.
Mir O, Brodowicz T, Italiano A, Wallet J, Blay JY, Bertucci F, Chevreau C, Piperno-Neumann S, Bompas E, Salas S, Perrin C, Delcambre C, Liegl-Atzwanger B, Toulmonde M, Dumont S, Ray-Coquard I, Clisant S, Taieb S, Guillemet C, Rios M, Collard O, Bozec L, Cupissol D, Saada-Bouzid E, Lemaignan C, Eisterer W, Isambert N, Chaigneau L, Cesne AL, Penel N. Mir O, et al. Lancet Oncol. 2016 Dec;17(12):1732-1742. doi: 10.1016/S1470-2045(16)30507-1. Epub 2016 Oct 14. Lancet Oncol. 2016. PMID: 27751846 Clinical Trial.
343 results